PF-AtlasClinical Trials › NCT03914196

Fontan Associated Liver Disease

Liver Stiffness Ultrasound · Not specified

Registry ID
NCT03914196
Phase
Not specified
Status
Active, not recruiting
Drug / intervention
Liver Stiffness Ultrasound
Sponsor
Children's Hospital Medical Center, Cincinnati
Start
2018-01-18
Enrollment
50
Locations
1

About this trial

Fontan-associated liver disease (FALD), including the development of cardiac cirrhosis and liver neoplasms (benign and malignant), occurs in a majority of patients with congenital heart disease palliated with the Fontan operation. However, the specific phenotype (fibrosis only, fibrosis + lesions, etc.) of disease and severity/timing of onset are variable. Chronic passive congestion of the liver due to the absence of a functional sub-pulmonary ventricle and resultant chronic central venous hypertension is suspected to be one of the chief drivers of FALD and recent work has demonstrated that ultrasound shear wave elastography can be used to noninvasively detect and measure the degree of liver congestion. Chronic passive congestion of the liver may also be a predictor of other Fontan-related complications, such as protein losing enteropathy, plastic bronchitis, and intractable ascites.

View NCT03914196 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT03914196 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.